lactic acid has been researched along with Peritoneal Diseases in 6 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Peritoneal Diseases: Pathological processes involving the PERITONEUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The combination of peritoneal exposure to dialysis fluids and administration of zopolrestat, a newly developed inhibitor of aldose reductase activity, resulted in less fibrosis and fewer peritoneal vessels than exposure to dialysis fluids only, in a long-term exposure model in the rat." | 3.73 | Effects of inhibition of the polyol pathway during chronic peritoneal exposure to a dialysis solution. ( Aberra, M; Aten, J; Deira, G; Dragt, CA; Krediet, RT; van Westrhenen, R, 2005) |
| "Significantly fewer postsurgical adhesions were seen after treatment with Adept, Hyalobarrier Gel, Interceed, PDLA membrane, and phospholipid emulsion than after Ringer's lactate solution." | 1.33 | Innovative barriers for peritoneal adhesion prevention: liquid or solid? A rat uterine horn model. ( Brochhausen, C; Brucker, S; Hierlemann, H; Solomayer, E; Wallwiener, C; Wallwiener, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, W | 1 |
| Zhang, X | 2 |
| Lin, B | 1 |
| Li, W | 1 |
| Hu, X | 1 |
| Cheng, J | 1 |
| Xu, Z | 1 |
| Chen, Z | 1 |
| Zhao, Y | 1 |
| He, T | 1 |
| Chen, K | 1 |
| Jiang, L | 1 |
| Zhang, J | 1 |
| Wan, H | 1 |
| Li, R | 1 |
| Lontra, MB | 1 |
| Bigolin, AV | 1 |
| Costa, RG | 1 |
| Grossi, JV | 1 |
| Scalco, P | 1 |
| Roll, S | 1 |
| Cavazzola, LT | 1 |
| Zareie, M | 1 |
| Hekking, LH | 1 |
| Welten, AG | 1 |
| Driesprong, BA | 1 |
| Schadee-Eestermans, IL | 1 |
| Faict, D | 1 |
| Leyssens, A | 1 |
| Schalkwijk, CG | 1 |
| Beelen, RH | 1 |
| ter Wee, PM | 1 |
| van den Born, J | 1 |
| van Westrhenen, R | 2 |
| Aten, J | 2 |
| Aberra, M | 1 |
| Dragt, CA | 1 |
| Deira, G | 1 |
| Krediet, RT | 2 |
| Wallwiener, M | 1 |
| Brucker, S | 1 |
| Hierlemann, H | 1 |
| Brochhausen, C | 1 |
| Solomayer, E | 1 |
| Wallwiener, C | 1 |
| Hajji, N | 1 |
| de Boer, OJ | 1 |
| Kunne, C | 1 |
| de Waart, DR | 1 |
1 trial available for lactic acid and Peritoneal Diseases
5 other studies available for lactic acid and Peritoneal Diseases
| Article | Year |
|---|---|
Effectiveness of the combined use of lactic acid film and polypropylene mesh in the formation of intraperitoneal adhesions--an experimental model in rats.
Topics: Animals; Combined Modality Therapy; Equipment Design; Lactic Acid; Peritoneal Diseases; Polypropylen | 2010 |
Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo.
Topics: Animals; Buffers; Dialysis Solutions; Glucose; Glycation End Products, Advanced; Hydrogen-Ion Concen | 2003 |
Effects of inhibition of the polyol pathway during chronic peritoneal exposure to a dialysis solution.
Topics: Aldehyde Reductase; Animals; Benzothiazoles; Dialysis Solutions; Enzyme Inhibitors; Fibrosis; Glucos | 2005 |
Innovative barriers for peritoneal adhesion prevention: liquid or solid? A rat uterine horn model.
Topics: Animals; Cellulose, Oxidized; Emulsions; Female; Gels; Isotonic Solutions; Lactic Acid; Membranes, A | 2006 |
Cyclosporin A induces peritoneal fibrosis and angiogenesis during chronic peritoneal exposure to a glucose-based, lactate-buffered dialysis solution in the rat.
Topics: Animals; Cyclosporine; Fibrosis; Glucose; Hemodialysis Solutions; Lactic Acid; Male; Neovascularizat | 2007 |